Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy.
about
Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy.Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.Endoplasmic reticulum stress-induced apoptotic pathway and mitochondrial dysregulation in HeLa cells treated with dichloromethane extract of Dillenia suffruticosa.Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers.
P2860
Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Comparison of hematological to ...... concurrent chemoradiotherapy.
@ast
Comparison of hematological to ...... concurrent chemoradiotherapy.
@en
type
label
Comparison of hematological to ...... concurrent chemoradiotherapy.
@ast
Comparison of hematological to ...... concurrent chemoradiotherapy.
@en
prefLabel
Comparison of hematological to ...... concurrent chemoradiotherapy.
@ast
Comparison of hematological to ...... concurrent chemoradiotherapy.
@en
P2093
P2860
P356
P1476
Comparison of hematological to ...... concurrent chemoradiotherapy.
@en
P2093
Hiroki Kiyohara
Shin-ei Noda
Takahiro Oike
Takashi Nakano
Tatsuya Ohno
Tomoaki Tamaki
P2860
P304
P356
10.1093/JRR/RRS121
P577
2012-12-14T00:00:00Z